Solei Systems Inc. (fka SOLI)

[multivalue]

https://www.sec.gov/litigation/suspensions/2020/34-88620-o.pdf

UNITED STATES OF AMERICA
Before the SECURITIES AND EXCHANGE COMMISSION April 10, 2020
In the Matter of Solei Systems, Inc.
File No. 500-1
ORDER OF SUSPENSION OF TRADING

It appears to the Securities and Exchange Commission that the public interest and the protection of investors require a suspension in the trading of the securities of Solei Systems, Inc. (“SOLI” or “the Company”) (CIK No. 0001750384) because of questions regarding the accuracy and adequacy of information in the marketplace since at least March 16, 2020. Those questions relate to statements SOLI made, in a press release issued by the Company on March 16, 2020 and a March 18, 2020 national cable news program interview with the Chief Executive Officer of its wholly-owned subsidiary, CareClix, Inc., about the ability of CareClix to provide COVID-19 testing kits that would allow a patient to submit a testing sample from home. SOLI is a Florida
corporation with its principal executive offices located in Alexandria, Virginia.
The Company’s common stock is quoted on OTC Link (previously Pink Sheets), operated by OTC Markets Group Inc., under the symbol SOLI. As of April 8, 2020, the stock had 12 market makers and was eligible for the “piggyback” exception of Rule 15c2-11(f)(3) under the Securities Exchange Act of 1934 (“Exchange Act”).

The Commission is of the opinion that the public interest and the protection of investors require a suspension of trading in the securities of the above-listed company. 2 THEREFORE, IT IS ORDERED, pursuant to Section 12(k) of the Exchange Act, that trading in the securities of the above-listed company is suspended for the period from 9:30 a.m. EDT on April 13, 2020, through 11:59 p.m. EDT on April 24, 2020.

By the Commission.
Vanessa A. Countryman
Secretary